Artiva Biotherapeutics Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Fred Aslan
Chief executive officer
US$1.1m
Total compensation
| CEO salary percentage | 52.8% |
| CEO tenure | 3.5yrs |
| CEO ownership | n/a |
| Management average tenure | 1.8yrs |
| Board average tenure | 3.8yrs |
Recent management updates
No updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | -US$26m |
| Dec 31 2023 | US$1m | US$584k | -US$29m |
| Mar 31 2023 | n/a | n/a | -US$63m |
| Dec 31 2022 | n/a | n/a | -US$59m |
| Mar 31 2022 | n/a | n/a | -US$41m |
| Dec 31 2021 | US$3m | US$480k | -US$72m |
Compensation vs Market: Fred's total compensation ($USD1.11M) is about average for companies of similar size in the US market ($USD1.45M).
Compensation vs Earnings: Fred's compensation has been consistent with company performance over the past year.
CEO
Fred Aslan (49 yo)
3.5yrs
Tenure
US$1,107,767
Compensation
Dr. Fred Aslan, M.D. is Founder of Adavium Medical, Inc. and serves as its Director. Dr. Aslan serves as President, Chief Executive Officer and Director at Artiva Biotherapeutics, Inc. since January 2021....
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 3.5yrs | US$1.11m | no data | |
| Co-Founder & Strategic Advisor | no data | US$762.47k | 0.17% $ 478.8k | |
| Executive VP | 3.8yrs | US$725.83k | 0.098% $ 273.6k | |
| Chief Technical Operations Officer | 2.6yrs | US$726.90k | no data | |
| CFO & Executive VP of Corporate Development | less than a year | no data | no data | |
| Chief Medical Officer | 2.1yrs | no data | no data | |
| Senior Vice President of Research & Early Development | 1.5yrs | no data | no data | |
| Senior Vice President of Regulatory Affairs | less than a year | no data | no data | |
| Senior Vice President of Clinical Operations | less than a year | no data | no data |
1.8yrs
Average Tenure
49yo
Average Age
Experienced Management: ARTV's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 3.5yrs | US$1.11m | no data | |
| Co-Founder & Strategic Advisor | no data | US$762.47k | 0.17% $ 478.8k | |
| Independent Director | 3.3yrs | US$70.82k | no data | |
| Advisor | no data | no data | no data | |
| Advisor | no data | no data | no data | |
| Advisor | no data | no data | no data | |
| Independent Chairman of the Board | 4.1yrs | no data | no data | |
| Director | 4.8yrs | no data | no data | |
| Advisor | no data | no data | no data | |
| Independent Director | 4.1yrs | no data | no data | |
| Advisor | no data | no data | no data | |
| Independent Director | 2.3yrs | US$46.82k | no data |
3.8yrs
Average Tenure
50yo
Average Age
Experienced Board: ARTV's board of directors are considered experienced (3.8 years average tenure).